Sothema

Sothema is the leading pharmaceutical company in Morocco and a major player in the African and Middle Eastern healthcare markets. Founded in 1976, the company specializes in the manufacturing and marketing of a wide range of pharmaceutical products, including generics, licensed brands, and biotechnologies. It is the first Moroccan company to produce insulin and has pioneered the production of biosimilars in Africa through strategic international technology transfers. The company operates as both a manufacturer of its own proprietary products and a Contract Development and Manufacturing Organization (CDMO) for over 35 global pharmaceutical leaders. Sothema is publicly traded on the Casablanca Stock Exchange and has been aggressively expanding its footprint through acquisitions and the development of high-value therapeutic areas such as oncology and hemodialysis.